Application and Effect
Bezafibrate is an antilipemic agent that lowers cholesterol and triglycerides. It decreases low density lipoproteins and increases high density lipoproteins. Bezafibrate lowers elevated blood lipids (triglycerides and cholesterol). Elevated VLDL and LDL are reduced by treatment with bezafibrate, whilst HDL-levels are increased. The activity of triglyceride lipases (lipoprotein lipase and hepatic lipoproteinlipase) involved in the catabolism of triglyceride-rich lipoproteins is increased by bezafibrate. Bezafibrate is a non-selective agonist of peroxisome proliferator-activated receptors .Bezaribrate is a hypolipidemic agent of the phenoxyaromatic acid class with antithrombotic effects.Product Sample
Product Packing:
Additional Information:
| Composition | C19H20ClNO4 |
| Assay | 99% |
| Appearance | White to Off-White powder |
| CAS No. | 41859-67-0 |
| Packing | 25KG 200KG |
| Shelf Life | 2 years |
| Storage | Store in cool and dry area |
| Certification | ISO. |